Feihe International, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Feihe International, Inc. - overview
Established
1985
Location
Beijing, -, China
Primary Industry
Food
About
Feihe International, Inc. is a prominent company in the infant nutrition sector, focusing on the development and distribution of scientifically formulated milk powder products for infants and young children. Founded in 1985, Feihe International, Inc. is based in Beijing, China.
The company specializes in providing infant formula products and underwent an IPO in November 2019, raising HKD 6700. 05 million. The firm has completed two deals since its inception, with the latest funding round being the IPO. The founder's history is not specified in the available data.
Feihe International specializes in milk powder products designed for infants and young children, with a primary focus on infant formula. Their products are based on extensive research conducted in collaboration with reputable institutions, such as Harvard Medical School and Tsinghua University. They have established a breast milk database and offer formulas that aim to replicate the nutritional profile of breast milk, ensuring the needs of infants during critical developmental stages are met. Feihe serves various international markets, concentrating on regions with substantial demand for premium infant nutrition, particularly in North America and Asia.
In 2021, Feihe International reported a revenue of HKD 3,530,345,411. 30 and an EBITDA of HKD 1,560,913,770. 10, highlighting its robust performance in the premium infant nutrition market. The company operates a B2C model to sell its products through online platforms and retail partnerships, fostering customer loyalty and engagement.
Following its IPO on November 12, 2019, where Feihe International raised HKD 6700. 05 million by selling 893. 34 million shares, the company aims to utilize the funds for launching new products and expanding into new geographic markets. Specific upcoming products are in development, focused on enhancing nutritional offerings.
Feihe plans to penetrate additional markets in Asia and North America by leveraging its established presence and reputation to cater to the growing demand for high-quality infant nutrition.
Current Investors
Morgan Stanley Private Equity Asia
Primary Industry
Food
Sub Industries
Dairy Products
Website
www.feihe.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Feihe International, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Xiaoyang Miaoke | - | ||||||||
| IPO | Completed | Feihe International, Inc. | - | ||||||||
| Add-on | Completed | Vitamin World USA Corporation | - | ||||||||
| Public to Private | Completed | Feihe International, Inc. | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.